spacer
home > epc > autumn 2019 > code of conduct
PUBLICATIONS
European Pharmaceutical Contractor

Code of Conduct





The regulatory world is nervously awaiting the full effects of the EU’s new requirements for medical and in vitro diagnostic device manufacturers that distribute products in EU markets. The retrofitted regulations place a greater emphasis on safety evidence that can be backed by clinical data and are, therefore, expected to have a considerable impact on the clinical research of any medical devices that are intended for EU markets. The coinciding unease triggered by the UK’s plausible ‘no-deal’ Brexit is intensifying anxieties about the regulatory changes and potential ripple effects. The looming deadlines and uncertainties provide ample reason for device organisations to make certain they understand the impending changes and ensure their clinical research data are ready for the revamped EU regulatory landscape.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
About the author


Patricia Santos-Serrao started her career in the life science industry in 1994 at Schering-Plough in Kenilworth, New Jersey, US, and later joined Boehringer Ingelheim Pharmaceuticals in Ridgefield, California. She took a leading role within both organisations in transitioning business processes, document management, and submission compilation from a paper to electronic system. Patricia is a member of RAPS and has earned her regulatory affairs certification from RAPS and the Regulatory Affairs Certification Board. She is a member of the DIA and the DIA-sponsored TMF Reference Model Working Group.
Print this page
Send to a friend
Privacy statement
News and Press Releases

Amcor partners with Moda to offer innovative packaging solutions

Amcor is pleased to announce its partnership with Moda vacuum packaging systems in North America and Latin America. By combining Amcor’s shrink bag and rollstock film for meat and cheese with Moda’s system, producers can gain operational efficiencies and drive total cost savings.
More info >>

White Papers

The current and future role of the medical oncologist in the professional care for cancer patients: a position paper by the European Society for Medical Oncology

European Society for Medical Oncology (ESMO)

  The number of cancer patients in Europe is rising and significant advances in basic and applied cancer research are making the provision of optimal care more challenging. The concept of cancer as a systemic, highly heterogeneous and complex disease has increased the awareness that quality cancer care should be provided by a multidisciplinary team (MDT) of highly qualified healthcare professionals. Cancer patients also have the right to benefit from medical progress by receiving optimal treatment from adequately trained and highly skilled medical professionals. Built on the highest standards of professional training and continuing medical education, medical oncology is recognised as an independent medical specialty in many European countries.
More info >>

 
Industry Events

2020 Avoca Quality and Innovation Summit

3-4 June 2020, Amsterdam, The Netherlands

The 2020 Avoca Quality and Innovation Summit will take place 3-4 June 2020, in Amsterdam, The Netherlands.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement